Literature DB >> 9200684

Cardiac muscarinic receptors. Cooperativity as the basis for multiple states of affinity.

P Chidiac1, M A Green, A B Pawagi, J W Wells.   

Abstract

Cooperativity has been investigated as the mechanistic basis for effects observed with cardiac muscarinic receptors in washed membranes from Syrian hamsters. Specifically, N-[3H]methylscopolamine labeled only 66-75% of the sites labeled by [3H]quinuclidinylbenzilate at apparently saturating concentrations of each radioligand. Also, receptors labeled by N-[3H]methylscopolamine revealed three states of affinity for agonists, both in native membranes and following irreversible blockade of about 80% of the sites by propylbenzilylcholine mustard; in both preparations, guanylylimidodiphosphate (GMP-PNP) effected an apparent interconversion of sites from higher to lower affinity for agonists and from lower to higher affinity for the antagonist. Excellent and mechanistically consistent descriptions of the data were obtained in terms of a model comprising cooperative and noncooperative forms of the receptor; the former was described by a variant of the Adair equation, and the latter was included to account for low-affinity sites that survived treatment with the mustard. If differences in apparent capacity derive from negative cooperativity in the binding of N-[3H]methylscopolamine, the cooperative form of the receptor was at least trivalent in native membranes; otherwise, constraints imposed by the effects of GMP-PNP at the concentrations of radioligand used in the assays dictate that the cooperative form of the receptor was at least tetravalent. In contrast, a divalent receptor is sufficient with the data from alkylated membranes, in accord with the reduced likelihood of interactions between functional sites within an oligomeric array. A model is presented wherein the receptor interconverts spontaneously between two or more states differing in their cooperative properties. The effects of GMP-PNP can be rationalized as a shift in the equilibrium between the different states.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9200684     DOI: 10.1021/bi961939t

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  26 in total

1.  Analysis of ligand-receptor interactions from the molecular level to the whole-body level.

Authors:  B N Manukhin
Journal:  Neurosci Behav Physiol       Date:  2002 May-Jun

2.  Oligomeric size of the m2 muscarinic receptor in live cells as determined by quantitative fluorescence resonance energy transfer.

Authors:  Luca F Pisterzi; David B Jansma; John Georgiou; Michael J Woodside; Judy Tai-Chieh Chou; Stéphane Angers; Valerica Raicu; James W Wells
Journal:  J Biol Chem       Date:  2010-03-19       Impact factor: 5.157

3.  Agonists at the δ-opioid receptor modify the binding of µ-receptor agonists to the µ-δ receptor hetero-oligomer.

Authors:  N Kabli; N Martin; T Fan; T Nguyen; A Hasbi; G Balboni; B F O'Dowd; S R George
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

Review 4.  Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes.

Authors:  Nicola J Smith; Graeme Milligan
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 5.  Oligomerization of G protein-coupled receptors: past, present, and future.

Authors:  Paul S-H Park; Slawomir Filipek; James W Wells; Krzysztof Palczewski
Journal:  Biochemistry       Date:  2004-12-21       Impact factor: 3.162

6.  Diversifying the repertoire of G protein-coupled receptors through oligomerization.

Authors:  Paul S-H Park; Krzysztof Palczewski
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-13       Impact factor: 11.205

Review 7.  Entropy and oligomerization in GPCRs.

Authors:  Rajkumar P Thummer; Matthew P Campbell; Mark K Dean; Marie J Frusher; Paul D Scott; Christopher A Reynolds
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 8.  On the fitting of binding data when receptor dimerization is suspected.

Authors:  J Giraldo
Journal:  Br J Pharmacol       Date:  2008-06-09       Impact factor: 8.739

9.  Bioluminescence resonance energy transfer studies reveal constitutive dimerization of the human lutropin receptor and a lack of correlation between receptor activation and the propensity for dimerization.

Authors:  Rongbin Guan; Xiuyan Feng; Xueqing Wu; Meilin Zhang; Xuesen Zhang; Terence E Hébert; Deborah L Segaloff
Journal:  J Biol Chem       Date:  2009-01-15       Impact factor: 5.157

Review 10.  Activation of G protein-coupled receptors: beyond two-state models and tertiary conformational changes.

Authors:  Paul S-H Park; David T Lodowski; Krzysztof Palczewski
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.